Airius PureAir PHI Cell Coronavirus Testing – Impact on Novel COVID-19


At Airius we are constantly developing and improving our products and establishing the effectiveness of the integrated PHI Cell from RGF Environmental in our PureAir Series of fan units on COVID19 is something high on our agenda. As defined by the World Health Organization, Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).

The recent COVID-19 illness is an infectious disease caused by the most recently discovered coronavirus. This new virus was unknown before the outbreak began in Wuhan, China, in December 2019.

Is PHI Cell technology in the Airius PureAir series effective at reducing COVID-19?

COVID-19 is a member of the enveloped RNA coronavirus (subgenus sarbecovirus, Orthocoronavirinae) subfamily. While Airius does not have testing specifically on COVID-19, we have validated test results showing 99+% reductions on similar viruses. These viruses, like COVID-19, are also ‘enveloped’ or protein jacketed virus types. If we can reduce these virus types, an assumption could be made that we would also be effective at reducing the current coronavirus at hand. Important to note that we make no medical claims.

Is PHI Cell technology in the Airius PureAir approved for use in hospitals and healthcare settings?

Many hospitals have approved and installed the Airius PureAir PHI-Cell technology throughout their facilities.

PHI Cell Coronavirus Testing on COVID-19

We currently do not have Airius PureAir Coronavirus testing specifically on the Wuhan Coronavirus (COVID-19). We are evaluating testing options with partners in both the U.S. and China. As there are a limited number of facilities capable of testing for this virus, their focus is on prioritising testing as it relates directly to the recent outbreaks.

While reviewing this bulletin Dr. Marsden (KSU) commented, “This virus apparently is similar to other viruses that we previously tested. There is every reason to believe that the Airius PureAir technology would be effective in reduction of COVID-19.” In combination with Airius PureAir technologies it is recommended to always follow antimicrobial protocols and procedures per regulatory guidelines.

Disclaimer: The PHI Cell technology from RGF Environmental integrated in Airius PureAir series units has not been tested on coronavirus (COVID-19) and is not a medical device therefore no medical claims are made. Testing conducted by independent accredited labs and universities.